| Brian D Rekus, MD | |
|
3215 N Northhills Blvd, Fayetteville, AR 72703-4424 | |
| (479) 463-7102 | |
| (479) 463-7864 |
| Full Name | Brian D Rekus |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 3215 N Northhills Blvd, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093759581 | NPI | - | NPPES |
| 208367508 | Medicaid | MO | |
| 191757 | Other | BLUE CROSS/BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2004019507 (Missouri) | Secondary |
| 208M00000X | Hospitalist | E-9358 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Regional Medical Center | Fayetteville, AR | Hospital |
| North Arkansas Regional Medical Center | Harrison, AR | Hospital |
| Siloam Springs Regional Hospital | Siloam springs, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Regional Medical System | 8820995434 | 219 |
News Archive
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
The Wall Street Journal reports that a senior FDA regulator is seeking stronger warnings about a class of blood pressure drugs that may be linked to higher cancer rates. Meanwhile, The New York Times details how a doctor hired by Merck to test a diabetes drug in rats found a possible link to pancreatic cancer, a discovery that turned the doctor into a crusader.
Scientists at Washington University School of Medicine in St. Louis working with diabetic mice have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes.
Imagine technology that allows you to get inside the mind of a terrorist to know how, when and where the next attack will occur. That's not nearly as far-fetched as it seems, according to a new Northwestern University study. Say, for purposes of illustration, that the chatter about an imminent terrorist attack is mounting, and specifics about the plan emerge, about weapons that will be used, the date of such a dreaded event and its location.
Valeant Pharmaceuticals International, Inc. announced today that Valeant has acquired Pedinol Pharmacal, Inc., a podiatry-focused, privately-owned specialty pharmaceutical company based in the U.S., for less than 1.5 times sales.
› Verified 5 days ago
| Entity Name | Washington Regional Medical System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306801485 PECOS PAC ID: 8820995434 Enrollment ID: O20051208000082 |
News Archive
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
The Wall Street Journal reports that a senior FDA regulator is seeking stronger warnings about a class of blood pressure drugs that may be linked to higher cancer rates. Meanwhile, The New York Times details how a doctor hired by Merck to test a diabetes drug in rats found a possible link to pancreatic cancer, a discovery that turned the doctor into a crusader.
Scientists at Washington University School of Medicine in St. Louis working with diabetic mice have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes.
Imagine technology that allows you to get inside the mind of a terrorist to know how, when and where the next attack will occur. That's not nearly as far-fetched as it seems, according to a new Northwestern University study. Say, for purposes of illustration, that the chatter about an imminent terrorist attack is mounting, and specifics about the plan emerge, about weapons that will be used, the date of such a dreaded event and its location.
Valeant Pharmaceuticals International, Inc. announced today that Valeant has acquired Pedinol Pharmacal, Inc., a podiatry-focused, privately-owned specialty pharmaceutical company based in the U.S., for less than 1.5 times sales.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian D Rekus, MD 12 East Appleby Road, Fayetteville, AR 72703 Ph: (479) 463-7102 | Brian D Rekus, MD 3215 N Northhills Blvd, Fayetteville, AR 72703-4424 Ph: (479) 463-7102 |
News Archive
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
The Wall Street Journal reports that a senior FDA regulator is seeking stronger warnings about a class of blood pressure drugs that may be linked to higher cancer rates. Meanwhile, The New York Times details how a doctor hired by Merck to test a diabetes drug in rats found a possible link to pancreatic cancer, a discovery that turned the doctor into a crusader.
Scientists at Washington University School of Medicine in St. Louis working with diabetic mice have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes.
Imagine technology that allows you to get inside the mind of a terrorist to know how, when and where the next attack will occur. That's not nearly as far-fetched as it seems, according to a new Northwestern University study. Say, for purposes of illustration, that the chatter about an imminent terrorist attack is mounting, and specifics about the plan emerge, about weapons that will be used, the date of such a dreaded event and its location.
Valeant Pharmaceuticals International, Inc. announced today that Valeant has acquired Pedinol Pharmacal, Inc., a podiatry-focused, privately-owned specialty pharmaceutical company based in the U.S., for less than 1.5 times sales.
› Verified 5 days ago
Jay P Hinkle, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3336 N. Futrall, Fayetteville, AR 72703 Phone: 479-463-3000 Fax: 479-463-3050 | |
Thida Win, M.D Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 | |
Jonna M. Dyer, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3215 N. North Hills Blvd., Fayetteville, AR 72703 Phone: 479-463-7102 Fax: 479-463-7864 | |
Dr. Fabian Enrique Latorre Jr., MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1125 N College Ave, Fayetteville, AR 72703 Phone: 479-521-8260 | |
Dr. Jon Garrett Mccowan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3215 N Northhills Blvd, Fayetteville, AR 72703 Phone: 479-463-7102 Fax: 479-463-7864 | |
Derinda Trobaugh, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3215 N Northhills Blvd, Fayetteville, AR 72703 Phone: 479-463-1000 | |
Michael A Bolding, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3215 N Northhills Blvd, Hospital Medicine Group, Fayetteville, AR 72703 Phone: 479-463-1000 |